Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 24 of 29

COMPLETED Phase 1

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy

NCT01084174
COMPLETED NA

Infant Nutrition: Evaluation of an Educational Touchscreen Computer Program

NCT01272492
COMPLETED Phase 1

Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis

NCT01024777
COMPLETED Phase 3

Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease

NCT01092390
COMPLETED NA

A Study of Family-based Cognitive-behavioral Therapy for Chronic Pediatric Headache and Anxiety

NCT01182051
COMPLETED NA

Nurse-Led Heart Failure Care Transition Intervention for African Americans: The Navigator Program

NCT01141907
COMPLETED Phase 2

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

NCT01077401
COMPLETED Phase 2

Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)

NCT00920699
TERMINATED NA

Memantine in Adult Autism Spectrum Disorder

NCT01078844
COMPLETED Phase 1

Sleep Apnea Treatment With Expiratory Resistance(Provent™)

NCT01061476
COMPLETED Phase 4

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

NCT01042158
COMPLETED NA

Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance

NCT01061242
COMPLETED Phase 1

The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery

NCT01579175
COMPLETED NA

Improving Childhood Immunization

NCT01794286
COMPLETED NA

Treatment for Psychological and Drug Abuse Problems

NCT01140334
COMPLETED Phase 3

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

NCT00934037
COMPLETED Phase 2

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

NCT01044758
COMPLETED Phase 1

Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

NCT01052701
COMPLETED NA

Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

NCT01142609
TERMINATED NA

Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric Emptying

NCT01481753
COMPLETED Phase 4

Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission

NCT01018056
COMPLETED Phase 2

Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome

NCT01029587
COMPLETED NA

Behavioral Intervention Study for Better Breast and Cervical Cancer Control for Korean American Women

NCT00857636
COMPLETED

Mechanical Alternans Study

NCT01557465
TERMINATED Phase 3

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

NCT01016522
COMPLETED Phase 3

Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)

NCT00990457
COMPLETED Phase 2

The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

NCT01003301
COMPLETED Phase 2

Preventing Postpartum Depression in African American Home Visiting Clients

NCT01175603
COMPLETED NA

The Effects of Broccoli Sprout Extract on Obstructive Lung Disease

NCT00994604
COMPLETED Phase 3

I Change Adherence & Raise Expectations

NCT01232478
COMPLETED Phase 4

Study of Ocular Penetration of Topically Administered Fluoroquinolones

NCT00924729
COMPLETED Phase 4

Ictal and Interictal Inflammatory Markers in Migraine

NCT01138150
TERMINATED Phase 2

Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates

NCT00986947
TERMINATED

Bariatric and Obstructive Lung Disease Study II

NCT01127399
COMPLETED Phase 1

Psilocybin and Spiritual Practice

NCT00802282
COMPLETED NA

Improving Wellness for Young Men

NCT01650233
TERMINATED Phase 1

SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

NCT00936520
TERMINATED Early Phase 1

Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy

NCT00956904
COMPLETED NA

Acupressure and Acupuncture as an Intervention With Children With Autism II

NCT00935701
COMPLETED NA

Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience

NCT01013896
COMPLETED Phase 3

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

NCT00784134
COMPLETED Phase 2

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

NCT00887458
COMPLETED NA

Potassium Intake in Patients With Chronic Kidney Disease

NCT00949585
COMPLETED Phase 2

Sodium Nitrite in Acute Myocardial Infarction

NCT00924118
COMPLETED NA

Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)

NCT01602159
COMPLETED Phase 2

Omalizumab in the Treatment of Peanut Allergy

NCT00949078
COMPLETED Phase 1

Sirolimus as Therapeutic Approach to Uveitis

NCT00908466
COMPLETED Phase 4

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

NCT00928005
TERMINATED NA

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

NCT00869414
COMPLETED Early Phase 1

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

NCT00894283
← Previous Page 24 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

Therapeutic Areas

Hypertension 15
Depression 12
HIV 11
Stroke 10
HIV Infections 8
Mild Cognitive Impairment 7
Dementia 7
Alzheimer Disease 7
Asthma 6
Insomnia 6

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.